Vince is an award-winning business lawyer, problem solver and dealmaker. His clients run the gamut from individual investors and entrepreneurs to widely held domestic and international corporations. Based in Portland, Oregon, he is Managing Partner of Harris Sliwoski and Editor of the Canna Law Blog and the Psychedelics Law Blog.
The DOJ Final Order on marijuana rescheduling dropped last week. Acting Attorney General Todd Blanche ordered that “FDA-approved drug products containing marijuana, as well [as] marijuana in any form covered by a state medical marijuana license, be placed in schedule III of the CSA.” The Order went further than many of us anticipated. It also
We got a new FDA cannabis enforcement memo on Wednesday, April 1, regarding “hemp-derived CBD research in medical research models.” The general thrust is FDA’s assurance that it won’t interfere with a new federal initiative, which covers up to $500 of hemp-derived products for eligible Medicare patients. That initiative is called the Substance Access Beneficiary
Sine die came for Oregon’s 2026 legislative session last Friday, March 6th. I previewed the roster of cannabis bills in play back on February 12th. Two of them passed; two of them failed. Below is a recap of the action, with links to each bill in the headers. HB 4139 (FAILED) This was the session’s
In the last year or two, we have seen a growing number of marijuana businesses take the position that IRC 280E no longer applies to them. Some of these businesses have taken that position in consultation with lawyers and CPAs. This shift in strategy predates Trump’s Executive Order of December 18, 2025, to reschedule marijuana
Oregon’s 2026 legislative session began last week on February 2. The biennial “short session” will last but 35 days, and focus on budget shortfalls, transportation and housing—which is to say that cannabis is not a priority. That said, of the 300 or so introduced bills, there are four cannabis-related submissions. That’s where I come in.
Last month, we hosted a webinar on federal cannabis law and policy in 2026. While things are not where we’d like them to be, it’s amazing to consider everything that has happened over the years. From a lawyering perspective, it’s almost unbelievable. I have worked as a business lawyer in the cannabis industry for over
It’s MLK Day once again. I have written an MLK Day post on this blog for nine consecutive years. The theme of all these posts is that cannabis is a civil rights issue, and that Dr. King would have advocated for ending marijuana prohibition based on that fact. Each year, I have demonstrated with facts
Register here Webinar overview This webinar will feature Harris Sliwoski attorneys Jason Adelstone (Denver, CO) and Vince Sliwoski (Portland, OR). Jason and Vince will examine a pair of significant developments for federal cannabis law and policy in 2026. These developments are: 1) last month’s Executive Order from President Trump, to reschedule marijuana from Schedule I
Welcome to the 10th annual “State of the State” post on Oregon cannabis. A great many things have changed over the years, and I’m planning to write another lookback post soon. For now, though, let’s cover everything that happened in 2025—which is a lot. Sales and market data According to OLCC data, total sales from
On Monday, the U.S. Supreme Court denied certiorari in Canna Provisions, Inc. et al. v. Bondi, a high-profile lawsuit that challenged the constitutionality of the federal prohibition of intrastate (and not interstate) cannabis activity. The denial offered no reasoning; nor was it accompanied by dissents or concurrences from any of the justices—all of which is
